Full name
UPPER FINANCE MED CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
UPPER FINANCE MED CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
UL. WIOŚLARSKA 10 / 5, 00-411 WARSZAWA
TAX ID7010281518
Rate company:
UPPER FINANCE MED CONSULTING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
TAX ID7010281518
KRS0000378597
Share capital5,000.00 zł
address
UL. WIOŚLARSKA 10 / 5, 00-411 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7010281518
REGON
142764138
KRS
0000378597
Legal form
limited liability company
Register Address
UL. WIOŚLARSKA 10 / 5, 00-411 WARSZAWA
Date of registration in KRS
2011-02-16
Date of commencement of economic activity
2011-02-16
Act signature
RDF/650661/24/724
Pkd codes
64.19.Z - Other monetary intermediation
64.91.Z - Financial leasing
64.92.Z - Other credit granting
64.99.Z - Other financial service activities, except insurance and pension funding not elsewhere classified
66.19.Z - Other activities auxiliary to financial services, except insurance and pension funding
66.21.Z - Risk and damage evaluation
66.29.Z - Other activities auxiliary to insurance and pension funding
70.22.Z - Business and other management consultancy activities
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 31,1 | -50,4 | -1,5 | 97 |
EBITDA | 31,1 | -50,4 | -1,5 | 97 |
Short time liabilities | 60,5 | 0 | 0,6 | -∞ |
Equity capital | 58,2 | 1,9 | 0,4 | -79,3 |
Operating profit (EBIT) | 31,1 | -50,4 | -1,5 | 97 |
Assets | 118,7 | 1,9 | 1 | -49,2 |
Net profit (loss) | 26,8 | -56,3 | -1,5 | 97,3 |
Cash | 1,8 | 0,9 | -0 | -104,2 |
Liabilities and provisions for liabilities | 60,5 | 0 | 0,6 | -∞ |
Net income from sale | 36 | 3 | 0 | -100 |
Working assets | 117,7 | 0,9 | -0 | -104,2 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 46 | -2975,3 | -382,2 | 2593,1 |
Equity capital to total assets | 49 | 100 | 40,8 | -59,2 |
Gross profit margin | 86,5 | -1678,4 | -1764,9 | |
EBITDA Margin | 86,5 | -1678,4 | -1764,9 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 613 | 0 | 2 147 483 648 | 2 147 483 648 |
Current financial liquidity indicator | 1.9460694789886475 | -0.0655263140797615 | -2 | |
Net dept to EBITDA | -0.058829594403505325 | 0.01774357631802559 | -0.02488705702126026 | 0 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.